Sign inJoin waitlistJoin the waitlist

Ronald T. Mitsuyasu

Associate Director, Center for HIV Identification, Prevention, and Treatment Services · UCLA

Credentials: · · ·

History

Clinical AIDS Research and Education (CARE) Center · UCLA
Present
UCLA
Present

Research

Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms
Science · 1987 · 814 citations
Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in the acquired immunodeficiency syndrome
New England Journal of Medicine · 1987 · 704 citations
Infection with HIV is associated with elevated IL-6 levels and production
The Journal of Immunology · 1990 · 594 citations

DA
David Aboulafia
25 papers · 2 as a fellow
SM
Steven Miles
20 papers · 2 as a fellow
RA
Richard Ambinder
19 papers
Joseph Sparano
15 papers
Lee Ratner
13 papers
AN
Ariela Noy
12 papers
David Henry
12 papers
Ethel Cesarman
10 papers
Juan Ramos
10 papers
Paul Volberding
10 papers
Richard Champlin
10 papers
Richard Pollard
10 papers

Grants

Consortium for Advancing Management and Prevention of Cancer in People with HIV
National Cancer Institute · UM1
Contact PI · $99.5M · Icahn School of Medicine at Mount Sinai
2006–2020
UCLA Center for AIDS Research (CFAR)
National Institute of Allergy and Infectious Diseases · P30
Project lead · $1.9M · University of California Los Angeles
2020
Studies on the Prevalence, Risk Factors and Outcomes of Cancers in HIV in India
National Cancer Institute · R21
Contact PI · $319.8K · University of California Los Angeles
2013–2016
South American Program in HIV Prevention Research (SAPHIR)
National Institute of Mental Health · R25
Contact PI · $773K · University of California Los Angeles
2011–2016

Clinical trials

Safety Study of a Dual Anti-HIV Gene Transfer Construct to Treat HIV-1 Infection
Principal investigator · Completed · Phase 1, Phase 2
Calimmune, Inc.
2013–2017
A Study to Compare the Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients
Study chair · Completed · Phase 3
Hoffmann-La Roche
1999
Safety and Effectiveness of Adding Either an HIV Vaccine, Interleukin-2, or Both to a Patient's Anti-HIV Drug Combination
Study chair · Completed · Phase 2
National Institute of Allergy and Infectious Diseases (NIAID)
2005
A Phase II Study of Intermittent Recombinant Human Interleukin-2 (rhIL-2) by Intravenous or Subcutaneous Administration in Subjects With HIV Infection on Highly Active Antiretroviral Therapy (HAART) Compared to HAART Alone
Study chair · Completed · Phase 2
National Institute of Allergy and Infectious Diseases (NIAID)
2007